000 04469nam a22003735i 4500
001 235171
003 ES-VaUE
005 20221220020648.0
007 cr nn 008mamaa
008 100301s2001 xxu| s |||| 0|eng d
020 _a9781592591381
024 7 _a10.1385/1592591388
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
245 1 0 _aMuscular Dystrophy
_bMethods and Protocols
_cedited by Katherine M.D. Bushby, Louise V.B. Anderson.
250 _a1st edition 2001
264 1 _aTotowa, NJ
_bHumana Press
_c2001
300 _a1 recurso en línea (XII, 458 páginas)
_b
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Medicine
_x1940-6037
_v43
505 0 _aBackground -- Application of Molecular Methodologies in Muscular Dystrophies -- Clinical Examination as a Tool for Diagnosis -- Histopathological Diagnosis of Muscular Dystrophies -- Serum Creatine Kinase in Progressive Muscular Dystrophies -- The molecular approach -- Deletion and Duplication Analysis in Males Affected with Duchenne or Becker Muscular Dystrophy -- Point Mutation Detection in the Dystrophin Gene -- DNA-Based Techniques for Detection of Carriers of Duchenne and Becker Muscular Dystrophy -- Fluorescence In Situ Hybridization Analysis for Carrier Detection in Duchenne/Becker Muscular Dystrophy -- DNA- Based Prenatal Diagnosis for Duchenne and Becker Muscular Dystrophy -- Molecular Diagnosis and Genetic Counseling of the Manifesting Carrier of Duchenne Muscular Dystrophy -- Mutation Analysis of X-Linked Emery-Dreifuss Muscular Dystrophy Gene -- Analysis of LAMA2 Gene in Merosin- Deficient Congenital Dystrophy -- ?-Sarcoglycan Mutations -- Mutation Detection in ?- and ?-Sarcoglycan (LGMD2E and LGMD2C) -- Mutation Analysis in ?-Sarcoglycan (LGMD2F) -- Molecular Diagnosis of Calpainopathies -- Molecular Investigation of LGMD2B-Haplotype Analysis and Mutation Screening -- Molecular Analysis of Facioscapulohumeral Muscular Dystrophy (FSHD1) -- Protein Analysis in the Muscular Dystrophies -- Analysis of Protein Expression in Muscular Dystrophies -- Immunological Reagents and Amplification Systems -- Immunocytochemical Analysis -- Multiplex Western Blot Analysis of Muscular Dystrophy Proteins -- Fetal Muscle Biopsy -- Use of Animal Models to Understand Human Muscular Dystrophy -- Options for Development of Gene-Based Therapy for Muscular Dystrophy.
520 _aWith the molecular mechanisms underlying the various forms of muscular dystrophy now rapidly clarifying, precise diagnosis has become a reality, and even a requirement in clinical practice. In Muscular Dystrophy: Methods and Protocols, Katherine Bushby and Louise Anderson have assembled an outstanding collection of key techniques for the analysis of DNA and protein from patients suspected to suffer from muscular dystrophy. Each method is highly detailed to ensure success and is presented by a hands-on expert who uses it on a day-to-day basis. The various DNA techniques focus on both the X-linked muscular dystrophies and the autosomal recessive muscular dystrophies. The protein methods include expression analysis, multiplex western blot analysis, immunocytochemical analysis, and reviews of immunological reagants and of amplification systems. Also discussed are the use of animal models to understand human muscular dystrophy and the available options for gene-based therapy. Comprehensive and highly practical, Muscular Dystrophy: Methods and Protocols offers today,s diagnostic laboratories, basic and medical researchers, and active clinicians an authoritative collection of tools that will serve as exacting diagnostic tools as well as greatly empowering research on the novel therapeutics now beginning to emerge.
700 1 _aBushby, Katherine M.D
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aAnderson, Louise V.B
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9781617371400
776 0 8 _iPrinted edition:
_z9780896036956
776 0 8 _iPrinted edition:
_z9781489942319
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/1592591388
_z(usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
988 _aSpringer_Protocols_2001
999 _c235171
_d235171